Generic placeholder image

Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1573-4064
ISSN (Online): 1875-6638

Research Article

Design, Synthesis, and Biological Evaluation of Novel C5-Modified Pyrimidine Ribofuranonucleosides as Potential Antitumor or/and Antiviral Agents

Author(s): Nikolaos Kollatos, Christos Mitsos, Stella Manta, Niki Tzioumaki, Christos Giannakas, Tania Alexouli, Aggeliki Panagiotopoulou, Dominique Schols, Graciela Andrei and Dimitri Komiotis*

Volume 16, Issue 3, 2020

Page: [368 - 384] Pages: 17

DOI: 10.2174/1573406415666190225112950

Price: $65

Abstract

Background: Nucleoside analogues are well-known antitumor, antiviral, and chemotherapeutic agents. Alterations on both their sugar and the heterocyclic parts may lead to significant changes in the spectrum of their biological activity and the degree of selective toxicity, as well as in their physicochemical properties.

Methods: C5-arylalkynyl-β-D-ribofuranonucleosides 3-6, 3΄-deoxy 12-15, 3΄-deoxy-3΄-C-methyl- β-D-ribofurananucleosides 18-21 and 2΄-deoxy-β-D-ribofuranonucleosides 23-26 of uracil, were synthesized using a one-step Sonogashira reaction under microwave irradiation and subsequent deprotection.

Results: All newly synthesized nucleosides were tested for their antitumor or antiviral activity. Moderate cytostatic activity against cervix carcinoma (HeLa), murine leukemia (L1210) and human lymphocyte (CEM) tumor cell lines was displayed by the protected 3΄-deoxy derivatives 12b,12c,12d, and the 3΄-deoxy-3΄-methyl 18a,18b,18c. The antiviral evaluation revealed appreciable activity against Coxsackie virus B4, Respiratory syncytial virus, Yellow Fever Virus and Human Coronavirus (229E) for the 3΄-deoxy compounds 12b,14, and the 3΄-deoxy-3΄-methyl 18a,18c,18d, accompanied by low cytotoxicity.

Conclusion: This report describes the total and facile synthesis of modified furanononucleosides of uracil, with alterations on both the sugar and the heterocyclic portions. Compounds 12b,14 and 18a,c,d showed noticeable antiviral activity against a series of RNA viruses and merit further biological and structural optimization investigations.

Keywords: Sonogashira reaction, C5-pyrimidine ribofurano nucleosides, microwave irradiation, cytotoxic activity, antiviral activity.

Graphical Abstract
[1]
Zhou, W.; Gumina, G.; Chong, Y.; Wang, J.; Shinazi, R.F.; Chu, C.K. Synthesis, structure-activity relationships, and drug resistance of β-D-3´-fluoro-2´,3´-unsaturated nucleosides as anti-HIV agents. J. Med. Chem., 2004, 47, 3399-3408.
[2]
Perigaud, C.; Gosselin, G.; Imbach, J.L. Nucleoside analogues as chemotherapeutic agents: A review. Nucleosides Nucleotides, 1992, 11, 903-945.
[3]
Brinkman, K.; Kakuda, T.N. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? Curr. Opin. Infect. Dis., 2000, 13, 5-11.
[4]
Johnson, A.A.; Ray, A.S.; Hanes, J. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem., 2001, 276, 40847-40857.
[5]
Robins, R.K.; Kini, G.D. Purines and purine nucleoside analogues as antitumor agents. In: The Chemistry of Antitumor Agents; Wilman, D.E.V., Ed.; Chapman and Hall: New York, 1990; pp. 299-321.
[6]
MacCoss, M.; Robins, M.J. Anticancer pyrimidines, pyrimidine nucleosides and prodrugs. In: The chemistry of Antitumor Agents; Wilman, D.E.V., Ed.; Chapman and Hall: New York, 1990; pp. 261-298.
[7]
Lagoja, I.M. Pyrimidine as costituent of natural biologically active compounds. Chem. Biodivers., 2005, 2, 1-50.
[8]
De Clercq, E.; Descamps, J.; Balzarini, J.; Giziewicz, J.; Barr, P.J.; Robins, M.J. Nucleic acid related compounds. 40. Synthesis and biological activities of 5-alkynyluracil nucleosides. J. Med. Chem., 1983, 26, 661-666.
[9]
Efangea, S.M.N.; Cheng, Y.C.; Bardos, T.J. Synthesis and biological activities of 2-Pyrimidinone Nucleosides. III.1,25-Alkynyl-2-Pyrimidinone 2′-Deoxyribosides. Nucleosides Nucleotides, 1985, 4, 545-564.
[10]
Vincent, P.; Beaucourt, J.P.; Pichat, L.; Balzarini, J.; De Clercq, E. Syntheses, activites biologiques et etude conformationnelle D’Alcynyl-5 desoxy-2′ uridines. Nucleosides Nucleotides, 1985, 4, 429-445.
[11]
Rai, D.; Johar, M.; Manning, T.; Agrawal, B.; Kunimoto, D.Y.; Kumar, R. Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria. J. Med. Chem., 2005, 48, 7012-7017.
[12]
Tsoukala, E.; Manta, S.; Kiritsis, C.; Komiotis, D. Keto and exomethylene pyranonucleosides as antitumor agents. Mini Rev. Med. Chem., 2012, 12, 255-275.
[13]
Dimopoulou, A.; Manta, S.; Parmenopoulou, V.; Kollatos, N.; Christidou, O.; Triantakonstanti, V.V.; Schols, D.; Komiotis, D. An easy microwave-assisted synthesis of C8-alkynyl adenine pyranonucleosides as novel cytotoxic antitumor agents. Front Chem., 2015, 3, 1-7.
[14]
Tzioumaki, N.; Manta, S.; Tsoukala, E.; Vande Voorde, J.; Liekens, S.; Komiotis, D.; Balzarini, J. Synthesis and biological evaluation of unsaturated keto and exomethylene D-arabinopyranonucleoside analogs: Novel 5-fluorouracil analogs that target thymidylate synthase. Eur. J. Med. Chem., 2011, 46, 993-1005.
[15]
Manta, S.; Tsoukala, E.; Tzioumaki, N.; Goropevek, A.; Pamulapati, R.T.; Cenci, A.; Balzarini, J.; Komiotis, D. Dideoxy fluoro-ketopyranosyl nucleosides as potent antiviral agents: Synthesis and biological evaluation of 2,3- and 3,4-dideoxy-3- fluoro-4- and -2-keto-β-D-glucopyranosyl derivatives of N4 benzoyl cytosine. Eur. J. Med. Chem., 2009, 44, 2696-2704.
[16]
Tsoukala, E.; Agelis, G.; Cencic, A.; Dolins, J.; Komiotis, D.; Botic, T. An efficient synthesis of 3-fluoro-5-thio-xylofuranosyl nucleosides of thymine, uracil, and 5- fluorouracil as potential antitumor or/and antiviral agents. Bioorg. Med. Chem., 2007, 15, 3241-3247.
[17]
Spanou, C.; Manta, S.; Komiotis, D.; Dervishi, A.; Kouretas, D. Antioxidant activity of a series of fluorinated pyrano-nucleoside analogues of N4-benzoyl cytosine and N6-benzoyl adenine. Int. J. Mol. Sci., 2007, 8, 695-704.
[18]
Haouz, A.; Vanheusden, V.; Munier-Lechman, H.; Froeyen, M.; Herdewijn, P.; Van Galenbergh, S.; Delarue, M. Enzymatic and structural analysis of inhibitors designed against Mycobacteriumtuberculosis thymidylate kinase. J. Biol. Chem., 2003, 278, 4963-4971.
[19]
Dimopoulou, A.; Manta, S.; Kiritsis, C.; Gkaragkouni, D.N.; Papasotiriou, I.; Balzarini, J.; Komiotis, D. Rapid microwave-enhanced synthesis of C5-alkynyl pyranonucleosides as novel cytotoxic antitumor agents. Bioorg. Med. Chem. Lett., 2013, 23, 1330-1333.
[20]
Kollatos, N.; Manta, S.; Dimopoulou, A.; Parmenopoulou, V.; Triantakonstanti, V.V.; Kellici, T.; Mavromoustakos, T.; Schols, D.; Komiotis, D. Branched-chain sugar nucleosides: stereocontrolled synthesis and bioevaluation of novel 3′-C-trifluoromethyl and 3′-C-methyl pyranonucleosides. Carbohydr. Res., 2015, 407, 170-178.
[21]
Mignon, P.; Loverix, S.; De Proft, F.; Geerlings, P. Influence of stacking on hydrogen bonding: quantum chemical study on pyridine-benzene model complexes. J. Phys. Chem. A, 2004, 108, 6038-6044.
[22]
Mignon, P.; Loverix, S.; Geerlings, P. Interplay between π-π interactions and the H-bonding ability of aromatic nitrogen bases. Chem. Phys. Lett., 2005, 401, 40-46.
[23]
Meneni, S.; Ott, I.; Sergeant, C.D.; Sniady, A.; Gust, R.; Dembinski, R. 5- Alkynyl-2′-deoxyuridines: chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cells. Bioorg. Med. Chem., 2007, 15, 3082-3088.
[24]
Gosselin, G.; Puech, F.; Genu-Dellac, C.; Imbach, J.L. 1,2-Di-O-acetyl-5-O-benzoyl-3-deoxy-3-fluoro-D-xylofuranose*. A versatile precursor for thesynthesis of 3-deoxy-3-fluoro-β-D-xylofuranosyl nucleosides as potential antiviral agents. Carbohydr. Res., 1993, 249, 1-17.
[25]
Couturier, S.; Aljarah, M.; Gosselin, G.; Christophe Mathea, C.; Christian Perigaud, C. Synthesis of 3´-deoxy-3´-C-methyl-β-D-ribonucleoside analogs. Tetrahedron, 2007, 63, 11260-11266.
[26]
Tong, G.L.; Lee, W.W.; Goodman, L. Synthesis of some 3´-O- methyl purine ribonucleosides. J. Org. Chem., 1967, 32, 1984-1986.
[27]
Vorbruggen, H.; Bennua, B. A new simplified nucleoside synthesis. Chem. Ber., 1981, 114, 1279-1286.
[28]
Vanheusden, V.; Busson, R.; Herdewijn, P.; Van Calenbergh, S. Synthesis and conformational analysis of 1‐[2,4‐dideo-xy‐4‐C‐hydroxymethyl‐alpha‐L‐lyxopyranosyl]thymine. J. Org. Chem., 2004, 69, 4446-4453.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy